Meningococcal disease is characterized by severe and rapidly progressing symptoms, often resulting in death or serious permanent sequelae, including limb amputations.
Thirty-three patients were allocated to receive treatment but 2 patients did not receive treatment as they were removed from the study due to rapidly progressing symptoms while awaiting KRAS testing.
As the disease progresses, symptoms include inability to complete activities of daily living, agitation, and mutism.
As the disease progresses, symptoms may include autonomic disturbances and cognitive and behavioral changes.
If the infection progresses, symptoms might include rashes on other parts of the body, joint pains, or swollen glands.
Despite an overall progress, symptoms may also fluctuate over the course of progressing dementia for random reasons.
As the disease progresses, symptoms reflect the organs involved, most commonly the heart and the kidneys [ 5].
When disease progresses, symptoms become more prominent and include focal neurological signs and convulsions, which might lead, in the final stage, to irreversible neurological damage or even death.
After the 3 individual sessions have concluded, the OT makes 3 brief follow-up phone calls (1 call per week) to discuss activity pacing progress, symptoms, and any barriers.
We used the incubation period distribution to estimate the proportion of passengers who progressed to symptom onset in flight.
It is associated with reduced life expectancy, cardiovascular problems, a variety of insidiously progressing detrimental symptoms and metabolic malfunction.
